Global HIV Diagnostics Market Detail Analysis focusing on Key Players Merck, Sysmex Partec, PointCare Technologies, Alere, Qiagen, Apogee Flow Systems, Cepheid, Roche Diagnostics, Hologic, Beckman Coulter Biomedical, ChemBio Diagnostics, Abbott

Market Study Report adds Global HIV Diagnostics market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years.

U.S. HIV diagnostics market held the largest revenue in North America valued at USD 876.8 in 2017 and will grow significantly over the forecast timeline. Growth is attributable to increasing prevalence of HIV infection in the country coupled with high awareness among people regarding HIV diagnosis and treatment. Moreover, strong foothold of key industry players in the U.S., and regulatory support coupled with high healthcare expenditure will favor HIV diagnostics business growth.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467735/?utm_source=openpr.com-AN

Moreover, HIV point of care test (POCT) used to provide quick results and approved for screening will accelerate industry growth. Improved access to HIV tests and associated diagnostics will increase adoption of POCT during forthcoming years. Growing need to combine these technologies efficiently and cost-effectively into existing laboratory networks and clinical algorithms will favor HIV diagnostics business growth. However, low penetration of HIV diagnostics in under-developed or poorly resourced countries due to limited access to lifesaving treatments may impede the industry growth in the foreseeable future.

Antibody tests segment accounted for more than 33% revenue share in 2017 and is expected to show considerable growth over forecast period. The growth is attributable to rising incidences of HIV infection across the globe. Availability of several antibody tests such as rapid and home tests for early HIV detection will further increase its adoption over the coming years. Rising awareness among people regarding regular blood tests and increasing prevalence of HIV symptoms will favor business growth.

Viral load testing segment is projected to experience lucrative CAGR of 9.2% over the forecast period. Growing need for early detection of HIV infection and monitoring treatment progress will fuel viral load testing market growth. Growing technological advancements such as branched DNA (bDNA), nucleic acid sequence-based amplification assay (NASBA) and reverse transcription polymerase chain reaction (RT-PCR) to determine blood HIV viral load will augment the segment growth.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467735/

HIV Diagnostics Market will exceed USD 5 billion by 2024; as per a new research report. Growing prevalence of HIV across the globe will drive HIV diagnostics industry growth during the forecast period. According to the UNAIDS?s data in 2017, more than 35 million people across the world, were living with HIV. Additionally, about 1.8 million new cases were diagnosed with HIV infection in 2017. This will surge the demand for HIV diagnostics thereby positively influencing the business growth. Favorable regulatory scenario coupled with fair reimbursement for HIV diagnostics will further spur HIV diagnostics market in the coming years.

Some of the players operating in HIV diagnostics market are Siemens Healthineers, Merck, Sysmex Partec, PointCare Technologies, Alere, Qiagen, Apogee Flow Systems, Cepheid, Roche Diagnostics, Hologic, Beckman Coulter Biomedical, ChemBio Diagnostics, Abbott, Biomerieux and BD Biosciences. Prime focus of the industry players is on inorganic strategies including acquisitions, merger, partnership and new product launch to strengthen their existing product portfolio and maintain market position.

Selected points from Table of Contents of this report:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. HIV Diagnostics Industry Insights

Chapter 4. HIV Diagnostics Market, By Product

Chapter 5. HIV Diagnostics Market, By Region

Chapter 6. Company Profiles

For More Details on this report at: https://www.marketstudyreport.com/reports/hiv-diagnostics-market

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Web site: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.